Related Experiment Videos

Seropositivity to Chlamydia pneumoniae or Helicobacter pylori and coronary artery disease

Alexios Sotiropoulos, Aristofanis Gikas, Sotirios Skourtis

    International Journal of Cardiology
    |July 5, 2005
    PubMed

    Insights

    This study found no significant link between Chlamydia pneumoniae or Helicobacter pylori infections and coronary artery disease (CAD). Evidence suggests these infections are not associated with angiographically confirmed CAD.

    Area of Science:

    • Cardiology
    • Infectious Diseases
    • Epidemiology

    Background:

    • The potential link between infections like Chlamydia pneumoniae and Helicobacter pylori and the development of coronary artery disease (CAD) remains a subject of ongoing research and debate.
    • This study aimed to clarify the association between serologic evidence of C. pneumoniae and H. pylori infections and the presence of angiographically confirmed CAD.

    Discussion:

    • Despite previous research suggesting a connection, this investigation found no statistically significant difference in seropositivity rates for C. pneumoniae (91% vs 86%) or H. pylori (77% vs 68%) between patients with CAD and control groups.
    • Multivariate analysis, which accounted for various cardiovascular risk factors including age, sex, diabetes, hypertension, obesity, smoking, family history, and lipid profiles, did not alter these findings, reinforcing the lack of association.

    Key Insights:

    • Seropositivity for Chlamydia pneumoniae was observed in 91% of CAD patients and 86% of controls (P>0.05).
    • Seroprevalence for Helicobacter pylori was 77% in CAD patients and 68% in controls (P>0.05).
    • Adjusted analyses confirmed no significant association between serologic status for either pathogen and angiographically confirmed CAD.

    Outlook:

    • Further research may explore other infectious agents or pathomechanisms potentially involved in CAD.
    • These findings contribute to the existing body of evidence suggesting that C. pneumoniae and H. pylori are unlikely to be primary drivers of CAD.
    • The study underscores the importance of considering established risk factors in the multifactorial etiology of coronary artery disease.

    Related Concept Videos

    Psychoneuroimmunology: Cardiovascular Disease01:27

    Psychoneuroimmunology: Cardiovascular Disease

    Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
    A key area of focus in PNI is the relationship between stress and coronary...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

    Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

    Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
    Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
    Gastritis II: Pathophysiology01:26

    Gastritis II: Pathophysiology

    The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
    Coronary Artery Disease III: Clinical Manifestations01:30

    Coronary Artery Disease III: Clinical Manifestations

    Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...